common glp 1 agonists GLP-1 Receptor Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care Clinical Focus on GLP-1 Agonists

SGLT inhibitors may protect kidneys by remodeling F-actin and -actinin-4 filaments, reducing 1-integrin loss on podocyte surfaces, blocking macrophage infiltration, activating M1-M2 polarization, and preventing profibrotic M2 macrophages

However, its important to note that animal studies dont always indicate what may happen in humans

Nur Wirkstoffe (keine Hilfsstoffe, keine Farbstoffe, laut Gesetz keine Konservierungsstoffe, keine technologischen Zustze wie Binde- und Trennmittel, keine versteckten Zusatzstoffe, frei von Gluten, Geschmacksverstrkern, Lactose, Aromen, Soja)

Its also gentle on the stomach and well-absorbed by the body, making it ideal for those with sensitive digestion

Enzyme Microb Technol 26:737742